Who Owns LB Pharmaceuticals Stock?
NASDAQ: LBRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 102.44%
- Institutions (% of float)
- 102.69%
- Held by insiders
- 0.24%
- Institutional holders
- 172
- Institutions 99.8%
- Insiders 0.2%
- Public and other 0.0%
Who owns LB Pharmaceuticals stock?
Institutional investors own about 102.4% of LB Pharmaceuticals's shares, spread across 172 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.24% of LBRX.
The largest institutional holders are Deep Track Capital, Lp (10.39%), Blackrock Inc. (8.48%) and RA Capital Management, L.P. (6.85%). Together, the top 10 institutions control 56.2% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their LBRX positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of LBRX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Deep Track Capital, Lp | 3.35M | 10.39% | 0.0% |
| Blackrock Inc. | 2.73M | 8.48% | +10.7% |
| RA Capital Management, L.P. | 2.21M | 6.85% | 0.0% |
| Trails Edge Capital Partners, LP | 1.52M | 4.72% | +15.4% |
| Commodore Capital Lp | 1.50M | 4.65% | 0.0% |
| JPMORGAN CHASE & CO | 1.50M | 4.64% | +4.9% |
| TCG Crossover Management, LLC | 1.45M | 4.49% | -21.3% |
| Caligan Partners, LP | 1.44M | 4.46% | 0.0% |
| Spruce Street Capital LP | 1.38M | 4.27% | 0.0% |
| Nantahala Capital Management, LLC | 1.05M | 3.26% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of LBRX
| Fund | Shares | % Held |
|---|---|---|
| JPMorgan Trust II-JPMorgan Small Cap Growth Fund | 692.90K | 2.15% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 672.00K | 2.08% |
| iShares Trust-iShares Russell 2000 ETF | 573.03K | 1.78% |
| BlackRock Funds-BlackRock Health Sciences Opportunities Portfolio | 567.63K | 1.76% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 278.89K | 0.86% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 244.91K | 0.76% |
| Prudential Sector Funds, Inc.-PGIM Jennison Health Sciences Fund | 231.15K | 0.72% |
| JPMorgan Trust I-JPMorgan Small Cap Blend Fund | 220.24K | 0.68% |
| BlackRock Health Sciences Term Trust | 207.99K | 0.64% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 197.23K | 0.61% |
Frequently asked questions
Who is the largest shareholder of LB Pharmaceuticals?
Deep Track Capital, Lp is the largest institutional shareholder of LBRX, owning 10.39% of shares outstanding (3.35M shares) as of its latest 13F filing.
What percentage of LB Pharmaceuticals is owned by institutions?
Institutions own about 102.4% of LBRX shares and 102.7% of the public float.
How much of LB Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 0.24% of LBRX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.